West Pharmaceutical Services stock holds near its yearly range

Published on 09/22/2026 at 14:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

West Pharmaceutical Services stock closed at USD 241.19 on September 21, 2026, near the lower end of its range. Market capitalization reached USD 17.6 billion.

Reinraum-Fertigung von Vials, West Pharmaceutical, ISIN US9523901012 — West Pharmaceutical (ISIN US9523901012) stellt in sterilen Reinräumen Vials und Elastomer-Verschlüsse für Injektionssysteme her, Illustration mit AI erstellt.

West Pharmaceutical Services, Inc. (US9553061055) closed at USD 241.19 on the New York Stock Exchange on September 21, 2026. The stock stood near the lower end of its 52-week range of USD 240.61 to USD 352.79, giving the market level a clear valuation context.

Stock remains near its yearly low

The September 21, 2026 closing price was USD 0.58 above the 52-week low of USD 240.61 and USD 111.60 below the 52-week high of USD 352.79. That comparison places the stock only 0.24 percent above the lower boundary and 31.62 percent below the upper boundary.

Trading volume reached 1.83 million shares on September 21, 2026, while market capitalization stood at USD 17.6 billion. The figures describe a large listed healthcare supplier whose share price is trading close to its recent low rather than near the midpoint of its annual range.

Reported figures frame the valuation

West Pharmaceutical Services reported revenue of USD 2.89 billion for fiscal year 2025, compared with USD 2.93 billion in fiscal year 2024. The year-over-year change was a decline of 1.4 percent, making revenue development a key reference point for the current share valuation.

Adjusted earnings per share reached USD 6.68 in fiscal year 2025, compared with USD 7.07 in fiscal year 2024. The decrease of USD 0.39, or 5.5 percent, provides a quantified comparison for investors assessing why the stock remains close to its 52-week low.

Market level sets the immediate reference

The combination of a USD 17.6 billion market capitalization and fiscal-year 2025 adjusted earnings per share of USD 6.68 places the September 21, 2026 closing price in a clearly measurable earnings context. The share price is not being assessed against an isolated daily move, but against a 31.62 percent gap to the 52-week high and a 0.24 percent distance from the low.

West Pharmaceutical Services stock stays above USD 240

West Pharmaceutical Services stock closed at USD 241.19 on the New York Stock Exchange on September 21, 2026. The same market snapshot recorded a 52-week range of USD 240.61 to USD 352.79, volume of 1.83 million shares and market capitalization of USD 17.6 billion.